Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Denosumab × Breast × Clear all

Phase

Status

Sponsor Class

OTHER 14 INDUSTRY 8 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Genitourinary 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 38 Docetaxel 30 Paclitaxel 28 Tamoxifen 26 Doxorubicin 25 Trastuzumab 24 Radiotherapy 19 Letrozole 14 Epirubicin 14 Fluorouracil 10 Immunohistochemistry 9 Capecitabine 9 exemestane 8 Lapatinib 8 Bevacizumab 8 Anastrozole 8 Methotrexate 7 Gene Expression Profiling 7 Filgrastim 7 palbociclib 6 Zoledronic Acid 6 Surgical Procedures, Operative 6 Microarray Analysis 6 Magnetic Resonance Spectroscopy 6 Goserelin 6 Chemotherapy, Adjuvant 6 Carboplatin 6 Amplified Fragment Length Polymorphism Analysis 6 pertuzumab 5 Taxes 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03532087 2020-01-18

PERIDENO

Borstkanker Onderzoek Groep

Phase 2 Withdrawn

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡